Excellent outcomes in a case of complex re-do surgery requiring prolonged cardioplegia using a new cardioprotective approach: Adenocaine

Journal of Extra-Corporeal Technology

Volumn 40, Issue 3, 2008, Pages 203-205

  O'Rullian, James J ^a   Clayson, Stephen E ^a   Peragallo, Raul ^a  

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

Adenosine; Cardioplegia; Lidocaine; Microplegia; Myocardial protection; Polarized arrest

Indexed keywords

ADENOCAINE; ADENOSINE; ADRENALIN; ANTIBIOTIC AGENT; CARDIOVASCULAR AGENT; FRESH FROZEN PLASMA; INOTROPIC AGENT; LIDOCAINE; MAGNESIUM; NORADRENALIN; POTASSIUM; UNCLASSIFIED DRUG; VASOPRESSIN; CARDIOTONIC AGENT;

AGED; ANTIBIOTIC THERAPY; AORTA BALLOON; AORTA CLAMPING; AORTA VALVE; AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CARDIOVASCULAR EQUIPMENT; CASE REPORT; CONVALESCENCE; CORONARY HEMODYNAMICS; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL CIRCULATION; EXTUBATION; HEART PROTECTION; HEMATOCRIT; HEMODILUTION; HUMAN; HYPERKALEMIA; INTENSIVE CARE UNIT; MALE; MICROPLEGIA; MITRAL VALVE PROSTHESIS; MITRAL VALVE REPLACEMENT; MYOCARDIAL PROTECTION SYSTEM; OPERATION DURATION; PROSTHETIC VALVE ENDOCARDITIS; REOPERATION; TREATMENT OUTCOME; CARDIOVASCULAR SURGERY; DRUG COMBINATION; METHODOLOGY; MIDDLE AGED;

ADENOSINE; AGED; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; CARDIOVASCULAR SURGICAL PROCEDURES; DRUG THERAPY, COMBINATION; HUMANS; HYPERKALEMIA; LIDOCAINE; MAGNESIUM; MALE; MIDDLE AGED; REOPERATION; TREATMENT OUTCOME;

EID: 56149092016     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Rao V, Ivanov J, Weisel RD, Ikonomidis JS, Christakis GT, David TE. Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg. 1996;112:38-51. (Pubitemid 26268967)
2. Salazar E, Torres J, Barragan R, Lopez M, Lasses LA. Aortic valve replacement in patients 70 years and older. Clin Cardiol. 2004;27:565-70. (Pubitemid 39302650)
3. Doenst T, Borger MA, Weisel RD, Yau TM, Maganti M, Rao V. Relation between aortic cross-clamp time and mortality-not as straightforward as expected. Eur J Cardiothorac Surg. 2008;33:660-5.
4. Milano CA, White WD, Smith LR, et al. Coronary artery bypass in patients with severely depressed ventricular function. Ann Thorac Surg. 1993;56:487-93.
5. Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart. 2002;88:53-60. (Pubitemid 34665003)
6. Menasché P. Blood cardioplegia: do we still need to dilute? Ann Thorac Surg. 1996;62:957-60.
7. Corvera JS, Kin H, Dobson GP, et al. Polarized arrest with warm or cold adenosine-lidocaine blood cardioplegia is equivalent to hypothermic potassium blood cardioplegia. J Thorac Cardiovasc Surg. 2005;129:599-606. (Pubitemid 40311320)
8. Dobson GP, Jones MW. Adenosine and lidocaine: a new concept in non-depolarizing surgical myocardial arrest, protection, and preservation. J Thorac Cardiovasc Surg. 2004;127:794-805.
9. Canyon SJ, Dobson GP. Protection against ventricular arrhythmias and cardiac death using adenosine and lidocaine during regional ischemia in the in vivo rat. Am J Physiol Heart Circ Physiol. 2004;287:H1286-95.
10. Vinten-Johansen J, Zhao Z-Q, Corvera JS, et al. Adenosine in myocardial protection in on-pump and off-pump cardiac surgery. Ann Thorac Surg. 2003;75:S691-699. (Pubitemid 36184550)
11. Jin ZX, Zhang SL, Wang XM, et al. The myocardial protective effects of a moderate-potassium adenosine-lidocaine cardioplegia inpediatric cardiac surgery. J Thorac Cardiovasc Surg. Epub ahead of print May 2008.